• Enterprise value to EBIT forward of Cognition Therapeutics, Inc. – NASDAQ:CGTX TradingView Thu, 09 Jul 2026 16:49:55 GMT
• number of shareholders of cognition therapeutics, inc. – nasdaq:cgtx TradingView Sun, 05 Jul 2026 13:39:12 GMT
• cognition therapeutics, inc. financial disclosures & sec filings TradingView Thu, 02 Jul 2026 05:55:50 GMT
• H.C. Wainwright reiterates Cognition Therapeutics stock rating on FDA alignment Investing.com Wed, 01 Jul 2026 07:00:00 GMT
• FDA Aligns With Cognition Therapeutics on Phase 3 Trial Design for Zervimesine in DLB-Associated Psychosis NeurologyLive Tue, 30 Jun 2026 15:19:02 GMT
• Cognition Therapeutics Slides Amid Sector Weakness; Key Support Levels in Focus - Trading Ideas dars.gov.et Mon, 29 Jun 2026 14:46:10 GMT
• cognition therapeutics, inc.(nasdaqcm:cgtx) added to russell microcap growth benchmark index marketscreener.com Mon, 29 Jun 2026 12:26:34 GMT
• We're Keeping An Eye On Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate Moomoo Mon, 29 Jun 2026 07:00:00 GMT
• Cognition Therapeutics, Inc.(NasdaqCM: CGTX) added to Russell Microcap Index marketscreener.com Mon, 29 Jun 2026 05:46:45 GMT
• cognition therapeutics gets positive fda feedback over phase 3 study of dlb psychosis – but cgtx stock just crashed 33% MSN Mon, 29 Jun 2026 02:48:51 GMT
• Cognition Therapeutics, Inc.(NasdaqCM: CGTX) added to Russell 3000E Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• cognition therapeutics gets positive fda feedback over phase 3 study of dlb psychosis – but cgtx stock just crashed 33% MSN Sat, 27 Jun 2026 23:12:05 GMT
• cognition therapeutics gets positive fda feedback over phase 3 study of dlb psychosis – but cgtx stock just crashed 33% MSN Fri, 26 Jun 2026 20:20:29 GMT
• h.c. wainwright remains a buy on coya therapeutics, inc. (coya) The Globe and Mail Fri, 26 Jun 2026 12:52:17 GMT
• Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain Seeking Alpha Fri, 26 Jun 2026 07:00:00 GMT
• CGTX Q1 2026 Earnings: Narrower Loss Beats Estimates; Stock Rises on Progress in Alzheimer's Pipeline dars.gov.et Fri, 26 Jun 2026 07:00:00 GMT
• cognition therapeutics, inc. actuals & estimates (nasdaq:cgtx) TradingView Thu, 25 Jun 2026 14:20:01 GMT
• H.C. Wainwright Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Maintains Target Price $3 Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• cognition therapeutics stock rises on fda trial alignment Investing.com Thu, 25 Jun 2026 06:44:11 GMT
• cognition therapeutics receives fda alignment on phase 3 trial of zervimesine for dlb psychosis grafa.com Wed, 24 Jun 2026 15:57:00 GMT
• cognition therapeutics secures fda alignment for pivotal phase 3 trial of zervimesine in dlb psychosis, targeting first durable tr... Minichart Wed, 24 Jun 2026 13:50:00 GMT
• Cognition Therapeutics Agrees With FDA on Phase 3 Trial Framework for Psychosis Treatment marketscreener.com Wed, 24 Jun 2026 12:28:39 GMT
• Cognition Therapeutics stock rises on FDA trial alignment By Investing.com Investing.com Canada Wed, 24 Jun 2026 11:49:57 GMT
• cognition therapeutics aligned with fda on pivotal phase 3 design for zervimesine in dlb psychosis TradingView Wed, 24 Jun 2026 11:43:00 GMT
• FDA says DLB psychosis could be approvable in Cognition trial plan Stock Titan Wed, 24 Jun 2026 11:32:02 GMT
• Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX) Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33% Stocktwits Wed, 24 Jun 2026 07:00:00 GMT
• Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA M... Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• Cognition Therapeutics (NASDAQ: CGTX) wins FDA alignment on pivotal DLB psychosis study for zervimesine Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Cognition, FDA agree on late-stage trial for dementia therapy Seeking Alpha Wed, 24 Jun 2026 07:00:00 GMT
• form def 14a cognition therapeutics inc for: 23 june by investing.com Investing.com South Africa Wed, 24 Jun 2026 03:29:41 GMT
• Director at Cognition Therapeutics (CGTX) granted 25,000 RSUs Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Director at Cognition Therapeutics (CGTX) awarded 25,000 RSUs Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• RSU grant lifts Cognition Therapeutics (CGTX) director Peggy Wallace’s holdings Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Director at Cognition Therapeutics (CGTX) receives 25,000 RSUs and holds 73,500 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• H.C. Wainwright reiterates Cognition Therapeutics stock rating on patent news Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Cognition Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A. Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• [form 4] cognition therapeutics inc insider trading activity Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• form 4 cognition therapeutics inc for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 07:00:00 GMT
• cognition therapeutics inc (cgtx) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Cognition Therapeutics Shareholders Elect Directors, Ratify Auditor The Globe and Mail Fri, 19 Jun 2026 07:00:00 GMT
• cognition therapeutics inc (cgtx) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 11:24:44 GMT
• cognition therapeutics inc (cgtx) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:50:40 GMT
• Shareholders of Cognition Therapeutics (CGTX) reelect directors and ratify Ernst & Young Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• cognition therapeutics elects directors and ratifies auditor at annual meeting Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• cognition therapeutics inc (cgtx) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 05:38:44 GMT
• cognition therapeutics inc (cgtx) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 05:24:58 GMT
• Cognition Therapeutics Inc (CGTX) Institutional Confidence TradingKey Thu, 18 Jun 2026 01:05:32 GMT
• cognition therapeutics (cgtx) h.c. wainwright 26th annual global investment conference 2024 summary Quartr Wed, 17 Jun 2026 07:00:00 GMT
• cognition therapeutics inc (cgtx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 06:20:43 GMT
• cognition therapeutics inc (cgtx) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 05:48:24 GMT
• cognition therapeutics inc (cgtx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 05:46:39 GMT
• cognition therapeutics receives patent allowance for zervimesine Investing.com UK Wed, 17 Jun 2026 03:48:31 GMT
• Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT... Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• Alzheimer's and DLB drug CT1812 gets new patent shield into 2045 Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Cognition Therapeutics receives patent allowance for zervimesine By Investing.com Investing.com UK Tue, 16 Jun 2026 07:00:00 GMT
• cognition therapeutics receives notice of allowance for zervimesine patent application from uspto Quiver Quantitative Tue, 16 Jun 2026 07:00:00 GMT
• cognition therapeutics inc (cgtx) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• CGTX Q1 2026 Earnings: EPS Beat Exceeds Estimates; Cash Runway Supports Alzheimer’s Programs dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• Cognition Therapeutics (CGTX) Extends Slide: Shares Drop Nearly 5% as Key Support Level Nears - GEX Level dars.gov.et Tue, 09 Jun 2026 07:00:00 GMT
• cognition therapeutics (cgtx) gets a buy from h.c. wainwright The Globe and Mail Tue, 09 Jun 2026 07:00:00 GMT
• [8-K] COGNITION THERAPEUTICS INC Reports Material Event | CGTX 8-K Filing Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• Cognition Therapeutics advances zervimesine toward registrational DLB psychosis program; cash into Q2 2027 TradingView Thu, 04 Jun 2026 07:00:00 GMT
• cognition therapeutics (cgtx) jefferies global healthcare conference 2026 summary Quartr Thu, 04 Jun 2026 07:00:00 GMT
• Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies? Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• neuro drug developer to outline dlb psychosis plans at june events Stock Titan Mon, 01 Jun 2026 11:30:00 GMT
• Cognition Therapeutics, Inc. CEO Lisa Ricciardi to Present at June Financial Conferences on DLB Psychosis Registration Program Quiver Quantitative Mon, 01 Jun 2026 07:00:00 GMT
• cognition therapeutics participating in upcoming investor conferences Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• cgtx stock chart | cognition therapeutics inc (nasdaq:cgtx) ChartMill Fri, 29 May 2026 07:00:00 GMT
• cgtx stock price, quote & chart | cognition therapeutics inc (nasdaq:cgtx) ChartMill Wed, 27 May 2026 07:00:00 GMT
• cognition therapeutics conducts zervimesine meeting with fda TipRanks Thu, 21 May 2026 16:22:46 GMT
• fda, cognition discuss next trial for lewy body dementia psychosis drug Stock Titan Thu, 21 May 2026 11:32:15 GMT
• Cognition Therapeutics (CGTX) outlines FDA path for zervimesine DLB psychosis trial Stock Titan Thu, 21 May 2026 07:00:00 GMT
• Cognition Therapeutics completes FDA meeting, sees path for registrational DLB psychosis program TradingView Thu, 21 May 2026 07:00:00 GMT
• cognition therapeutics, inc. reports positive fda meeting on zervimesine development for dementia with lewy bodies psychosis | cgt... Quiver Quantitative Thu, 21 May 2026 07:00:00 GMT
• cognition therapeutics advances zervimesine (ct1812) toward registrational trial for dementia with lewy bodies psychosis after pos... Minichart Thu, 21 May 2026 07:00:00 GMT
• cognition therapeutics advances zervimesine toward late-stage dlb trial TipRanks Thu, 21 May 2026 07:00:00 GMT
• cognition therapeutics discusses fda meeting on dlb drug trial Investing.com Thu, 21 May 2026 07:00:00 GMT
• form 8k cognition therapeutics inc for: 21 may by investing.com Investing.com India Thu, 21 May 2026 07:00:00 GMT
• FDA, Cognition discuss next trial for Lewy body dementia psychosis drug Stock Titan Wed, 20 May 2026 07:00:00 GMT
• cognition therapeutics, inc. - common stock (nq: cgtx The Chronicle-Journal Mon, 18 May 2026 20:13:13 GMT
• donor extends 2-year access to experimental dlb therapy for 32 people Stock Titan Thu, 14 May 2026 11:32:32 GMT
• Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) i... GlobeNewswire Thu, 14 May 2026 07:00:00 GMT
• Cognition Therapeutics receives donation to extend DLB program Investing.com Thu, 14 May 2026 07:00:00 GMT
• press release: cognition therapeutics receives second philanthropic donation to extend ongoing expanded access program for zervime... Moomoo Thu, 14 May 2026 07:00:00 GMT
• ram selvaraju reiterates buy on cognition amid clinical progress and regulatory milestones, keeps 12-month price target unchanged ... TipRanks Mon, 11 May 2026 15:52:55 GMT
• Blocking Toxic Oligomers: The Science and Strategy Behind Zervimesine Psychiatric Times Mon, 11 May 2026 07:00:00 GMT
• h.c. wainwright maintains cognition therapeutics(cgtx.us) with buy rating, maintains target price $3 Moomoo Mon, 11 May 2026 07:00:00 GMT
• chardan capital maintains cognition therapeutics(cgtx.us) with buy rating, cuts target price to $4 Moomoo Sat, 09 May 2026 05:46:53 GMT
• chardan capital maintains cognition therapeutics(cgtx.us) with buy rating, cuts target price to $4 富途牛牛 Fri, 08 May 2026 22:29:32 GMT
• cognition therapeutics inc 1q 2026: net income $(4.57m), eps $(0.05) — 10-q summary TradingView Fri, 08 May 2026 07:00:00 GMT
• cognition therapeutics (nasdaq: cgtx) q1 2026 loss narrows on lower r&d Stock Titan Fri, 08 May 2026 07:00:00 GMT
• cognition therapeutics (nasdaq:cgtx) releases quarterly earnings results, beats estimates by $0.01 eps MarketBeat Fri, 08 May 2026 07:00:00 GMT
• Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• Dementia-drug developer gets May 20 FDA meeting as 2027 data loom Stock Titan Thu, 07 May 2026 07:00:00 GMT
• cognition therapeutics | 8-k: cognition therapeutics reports financial results for the first quarter 2026 and provides business up... Moomoo Thu, 07 May 2026 07:00:00 GMT
• cognition therapeutics (nasdaq: cgtx) cuts q1 2026 loss and projects cash runway into q2 2027 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• cognition therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Thu, 07 May 2026 07:00:00 GMT
• cognition therapeutics (nasdaq: cgtx) cfo has 8,567 shares withheld for taxes Stock Titan Mon, 04 May 2026 07:00:00 GMT
• cognition therapeutics inc expected to post a loss of 7 cents a share - earnings preview TradingView Fri, 01 May 2026 07:00:00 GMT
• cognition therapeutics (cgtx) to release earnings on wednesday MarketBeat Wed, 29 Apr 2026 11:54:33 GMT
• cognition therapeutics | def 14a: definitive information statements Moomoo Mon, 27 Apr 2026 22:43:42 GMT
• cognition therapeutics | ars: annual report to security holders Moomoo Mon, 27 Apr 2026 22:40:23 GMT
• cognition therapeutics (nasdaq: cgtx) outlines 2026 virtual meeting, director elections and ey ratification Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• cognition therapeutics cmo buys $11,100 in common stock by investing.com Investing.com India Tue, 21 Apr 2026 07:00:00 GMT
• cognition therapeutics, inc. (nasdaq:cgtx) given average recommendation of "moderate buy" by analysts MarketBeat Tue, 21 Apr 2026 07:00:00 GMT
• top brass makes bold move with fresh insider buying spree at cognition therapeutics TipRanks Tue, 21 Apr 2026 02:14:26 GMT
• insider buying: john doyle acquires 10,000 shares of cognition t GuruFocus Tue, 21 Apr 2026 01:54:48 GMT
• john brendan doyle purchases 10,000 shares of cognition therapeutics (nasdaq:cgtx) stock MarketBeat Mon, 20 Apr 2026 21:48:02 GMT
• cognition therapeutics | 4: statement of changes in beneficial ownership of securities-officer ricciardi lisa Moomoo Mon, 20 Apr 2026 20:17:33 GMT
• Cognition Therapeutics (CGTX) CEO buys 9,175 open-market shares Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• Cognition Therapeutics (CGTX) CFO adds 10,000 shares in open-market buy Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• cognition therapeutics cfo john doyle buys $11,299 in stock Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• insider buy: cognition therapeutics (cgtx) cmo adds 10,000 shares Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• cognition therapeutics ceo lisa ricciardi buys $10,092 in shares by investing.com Investing.com Canada Mon, 20 Apr 2026 07:00:00 GMT
• insider buying: john doyle acquires 10,000 shares of cognition t GuruFocus Mon, 20 Apr 2026 07:00:00 GMT
• cognition therapeutics cmo buys $11,100 in common stock by investing.com Investing.com Canada Mon, 20 Apr 2026 07:00:00 GMT
• lisa ricciardi acquires 9,175 shares of cognition therapeutics (nasdaq:cgtx) stock MarketBeat Mon, 20 Apr 2026 07:00:00 GMT
• cognition therapeutics (cgtx.us) achieved positive results in the ct1812 trial for alzheimer's disease medication. 富途牛牛 Thu, 16 Apr 2026 07:47:37 GMT
• cognition therapeutics targets faster dlb psychosis path as zervimesine nears late-stage plans Yahoo Finance Mon, 13 Apr 2026 20:35:29 GMT
• update report: can cognition therapeutics inc disrupt its industry - quarterly trade summary & weekly breakout opportunity watchli... baoquankhu1.vn Mon, 13 Apr 2026 13:29:37 GMT
• insider trends: whats the fair value of cognition therapeutics inc stock - sell signal & real-time market sentiment reports baoquankhu1.vn Mon, 13 Apr 2026 10:00:55 GMT
• cgtx: phase iii trials for zervimesine in dlb psychosis and alzheimer's are advancing with strong safety and efficacy data TradingView Mon, 13 Apr 2026 07:00:00 GMT
• insider sell: can cognition therapeutics inc disrupt its industry - portfolio gains summary & daily stock momentum reports baoquankhu1.vn Sun, 12 Apr 2026 03:07:11 GMT
• big picture: whats the fair value of cognition therapeutics inc stock - quarterly trade report & real-time chart pattern alerts baoquankhu1.vn Fri, 10 Apr 2026 17:31:40 GMT
• lewy body dementia market: accelerating growth and pipeline openPR.com Thu, 09 Apr 2026 07:00:00 GMT
• cognition therapeutics to detail clinical progress at april healthcare conference AD HOC NEWS Wed, 08 Apr 2026 07:00:00 GMT
• cognition therapeutics to detail clinical progress at april healthcare conference AD HOC NEWS Tue, 07 Apr 2026 23:42:44 GMT
• CEO to give Alzheimer's, Lewy body drug update on April 13 Stock Titan Tue, 07 Apr 2026 07:00:00 GMT
• cognition therapeutics to present at needham virtual healthcare conference GlobeNewswire Tue, 07 Apr 2026 07:00:00 GMT
• cognition therapeutics, inc. ceo lisa ricciardi to present at 25th annual needham virtual healthcare conference Quiver Quantitative Tue, 07 Apr 2026 07:00:00 GMT
• cognition therapeutics to present at needham virtual healthcare conference Bitget Mon, 06 Apr 2026 20:33:11 GMT
• fed meeting: what is the peg ratio of cognition therapeutics inc - 2026 outlook & risk adjusted buy/sell alerts baoquankhu1.vn Mon, 06 Apr 2026 12:27:17 GMT
• will cognition (cgtx) stock hit record highs | price at $0.89, up 1.96% - institutional buying Cổng thông tin điện tử tỉnh Tây Ninh Mon, 06 Apr 2026 07:00:00 GMT
Cognition Therapeutics Inc.(NASDAQ:CGTX) 
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 recept...
Website: http://www.cogrx.com
Founded: 2007
CEO: Hank Safferstein
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends